G. Mancia Et Al. , "Risk of adverse cardiovascular outcomes and new diabetes with combination therapy in hypertensive patients with coronary artery disease: the INternational VErapamil SR-Trandolapril STudy (INVEST)," ESC Congress 2004 , vol.25, Munich, Germany, pp.423-424, 2004
Mancia, G. Et Al. 2004. Risk of adverse cardiovascular outcomes and new diabetes with combination therapy in hypertensive patients with coronary artery disease: the INternational VErapamil SR-Trandolapril STudy (INVEST). ESC Congress 2004 , (Munich, Germany), 423-424.
Mancia, G., Keltai, M., Erdine, S., Hewkin, A., Kupfer, S., & Pelpine, C., (2004). Risk of adverse cardiovascular outcomes and new diabetes with combination therapy in hypertensive patients with coronary artery disease: the INternational VErapamil SR-Trandolapril STudy (INVEST) . ESC Congress 2004 (pp.423-424). Munich, Germany
Mancia, G Et Al. "Risk of adverse cardiovascular outcomes and new diabetes with combination therapy in hypertensive patients with coronary artery disease: the INternational VErapamil SR-Trandolapril STudy (INVEST)," ESC Congress 2004, Munich, Germany, 2004
Mancia, G Et Al. "Risk of adverse cardiovascular outcomes and new diabetes with combination therapy in hypertensive patients with coronary artery disease: the INternational VErapamil SR-Trandolapril STudy (INVEST)." ESC Congress 2004 , Munich, Germany, pp.423-424, 2004
Mancia, G. Et Al. (2004) . "Risk of adverse cardiovascular outcomes and new diabetes with combination therapy in hypertensive patients with coronary artery disease: the INternational VErapamil SR-Trandolapril STudy (INVEST)." ESC Congress 2004 , Munich, Germany, pp.423-424.
@conferencepaper{conferencepaper, author={G Mancia Et Al. }, title={Risk of adverse cardiovascular outcomes and new diabetes with combination therapy in hypertensive patients with coronary artery disease: the INternational VErapamil SR-Trandolapril STudy (INVEST)}, congress name={ESC Congress 2004}, city={Munich}, country={Germany}, year={2004}, pages={423-424} }